HEADER HYDROLASE 20-DEC-06 2OCK TITLE CRYSTAL STRUCTURE OF VALACYCLOVIR HYDROLASE D123N MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: VALACYCLOVIR HYDROLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: VACVASE, BIPHENYL HYDROLASE-LIKE PROTEIN, BIPHENYL COMPND 5 HYDROLASE-RELATED PROTEIN, BPH-RP, BREAST EPITHELIAL MUCIN-ASSOCIATED COMPND 6 ANTIGEN, MCNAA; COMPND 7 EC: 3.1.-.-; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BPHL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS ALPHA BETA HYDROLASE FOLD, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.LAI,Z.XU,G.L.AMIDON REVDAT 5 20-OCT-21 2OCK 1 REMARK SEQADV REVDAT 4 18-OCT-17 2OCK 1 REMARK REVDAT 3 24-FEB-09 2OCK 1 VERSN REVDAT 2 04-NOV-08 2OCK 1 JRNL REVDAT 1 05-FEB-08 2OCK 0 JRNL AUTH L.LAI,Z.XU,J.ZHOU,K.D.LEE,G.L.AMIDON JRNL TITL MOLECULAR BASIS OF PRODRUG ACTIVATION BY HUMAN JRNL TITL 2 VALACYCLOVIRASE, AN ALPHA-AMINO ACID ESTER HYDROLASE. JRNL REF J.BIOL.CHEM. V. 283 9318 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18256025 JRNL DOI 10.1074/JBC.M709530200 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 32415 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1600 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2025 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 285 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.89900 REMARK 3 B22 (A**2) : 0.89900 REMARK 3 B33 (A**2) : -1.79900 REMARK 3 B12 (A**2) : 0.47400 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.287 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.798 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.980 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.573 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 87.93 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OCK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040964. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32659 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 39.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.32200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 2OCG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 4,000, 0.1 M MOPS, 0.1 M REMARK 280 MNSO4, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.56867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.78433 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 57.56867 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.78433 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN. THE BIOLOGICAL UNIT OF THE REMARK 300 PROTEIN IS NOT KNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 MG MG A 302 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 166 CB OG REMARK 470 LYS A 167 CB CG CD CE NZ REMARK 470 ARG A 187 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 68 108.01 -52.75 REMARK 500 SER A 122 -127.82 60.75 REMARK 500 CYS A 208 27.87 -149.62 REMARK 500 LYS A 254 -158.24 -117.63 REMARK 500 ASN A 256 41.58 -94.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 301 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 57 OE1 REMARK 620 2 GLU A 57 OE2 57.3 REMARK 620 3 ASP A 78 OD2 102.8 159.8 REMARK 620 4 HOH A 303 O 84.1 86.5 88.1 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 302 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 204 OD2 REMARK 620 2 HOH A 410 O 95.9 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OCG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN VALACYCLOVIR HYDROLASE REMARK 900 RELATED ID: 2OCI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF VALACYCLOVIR HYDROLASE COMPLEXED WITH A REMARK 900 PRODUCT ANALOGUE REMARK 900 RELATED ID: 2OCL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF VALACYCLOVIR HYDROLASE S122A MUTANT DBREF 2OCK A 21 274 UNP Q86WA6 BPHL_HUMAN 38 291 SEQADV 2OCK ASN A 123 UNP Q86WA6 ASP 140 ENGINEERED MUTATION SEQRES 1 A 254 SER VAL THR SER ALA LYS VAL ALA VAL ASN GLY VAL GLN SEQRES 2 A 254 LEU HIS TYR GLN GLN THR GLY GLU GLY ASP HIS ALA VAL SEQRES 3 A 254 LEU LEU LEU PRO GLY MET LEU GLY SER GLY GLU THR ASP SEQRES 4 A 254 PHE GLY PRO GLN LEU LYS ASN LEU ASN LYS LYS LEU PHE SEQRES 5 A 254 THR VAL VAL ALA TRP ASP PRO ARG GLY TYR GLY HIS SER SEQRES 6 A 254 ARG PRO PRO ASP ARG ASP PHE PRO ALA ASP PHE PHE GLU SEQRES 7 A 254 ARG ASP ALA LYS ASP ALA VAL ASP LEU MET LYS ALA LEU SEQRES 8 A 254 LYS PHE LYS LYS VAL SER LEU LEU GLY TRP SER ASN GLY SEQRES 9 A 254 GLY ILE THR ALA LEU ILE ALA ALA ALA LYS TYR PRO SER SEQRES 10 A 254 TYR ILE HIS LYS MET VAL ILE TRP GLY ALA ASN ALA TYR SEQRES 11 A 254 VAL THR ASP GLU ASP SER MET ILE TYR GLU GLY ILE ARG SEQRES 12 A 254 ASP VAL SER LYS TRP SER GLU ARG THR ARG LYS PRO LEU SEQRES 13 A 254 GLU ALA LEU TYR GLY TYR ASP TYR PHE ALA ARG THR CYS SEQRES 14 A 254 GLU LYS TRP VAL ASP GLY ILE ARG GLN PHE LYS HIS LEU SEQRES 15 A 254 PRO ASP GLY ASN ILE CYS ARG HIS LEU LEU PRO ARG VAL SEQRES 16 A 254 GLN CYS PRO ALA LEU ILE VAL HIS GLY GLU LYS ASP PRO SEQRES 17 A 254 LEU VAL PRO ARG PHE HIS ALA ASP PHE ILE HIS LYS HIS SEQRES 18 A 254 VAL LYS GLY SER ARG LEU HIS LEU MET PRO GLU GLY LYS SEQRES 19 A 254 HIS ASN LEU HIS LEU ARG PHE ALA ASP GLU PHE ASN LYS SEQRES 20 A 254 LEU ALA GLU ASP PHE LEU GLN HET MN A 301 1 HET MG A 302 1 HETNAM MN MANGANESE (II) ION HETNAM MG MAGNESIUM ION FORMUL 2 MN MN 2+ FORMUL 3 MG MG 2+ FORMUL 4 HOH *285(H2 O) HELIX 1 1 SER A 55 PHE A 60 1 6 HELIX 2 2 PHE A 60 LEU A 67 1 8 HELIX 3 3 ASP A 95 LEU A 111 1 17 HELIX 4 4 SER A 122 TYR A 135 1 14 HELIX 5 5 THR A 152 ARG A 163 1 12 HELIX 6 6 ASP A 164 TRP A 168 5 5 HELIX 7 7 SER A 169 GLY A 181 1 13 HELIX 8 8 GLY A 181 GLN A 198 1 18 HELIX 9 9 PHE A 199 ASN A 206 5 8 HELIX 10 10 LEU A 211 VAL A 215 5 5 HELIX 11 11 PRO A 231 VAL A 242 1 12 HELIX 12 12 ASN A 256 PHE A 261 1 6 HELIX 13 13 PHE A 261 GLN A 274 1 14 SHEET 1 A 8 THR A 23 VAL A 29 0 SHEET 2 A 8 VAL A 32 GLY A 40 -1 O GLN A 38 N THR A 23 SHEET 3 A 8 PHE A 72 TRP A 77 -1 O VAL A 74 N THR A 39 SHEET 4 A 8 HIS A 44 LEU A 49 1 N LEU A 48 O VAL A 75 SHEET 5 A 8 VAL A 116 TRP A 121 1 O LEU A 119 N LEU A 49 SHEET 6 A 8 ILE A 139 TRP A 145 1 O VAL A 143 N LEU A 118 SHEET 7 A 8 ALA A 219 GLY A 224 1 O LEU A 220 N MET A 142 SHEET 8 A 8 ARG A 246 MET A 250 1 O ARG A 246 N ILE A 221 LINK OE1 GLU A 57 MN MN A 301 1555 1555 2.33 LINK OE2 GLU A 57 MN MN A 301 1555 1555 2.27 LINK OD2 ASP A 78 MN MN A 301 1555 1555 2.14 LINK OD2 ASP A 204 MG MG A 302 1555 1555 2.04 LINK MN MN A 301 O HOH A 303 1555 1555 2.22 LINK MG MG A 302 O HOH A 410 1555 1555 2.22 CISPEP 1 ARG A 86 PRO A 87 0 -0.07 CISPEP 2 PRO A 87 PRO A 88 0 0.33 SITE 1 AC1 5 HIS A 35 GLU A 57 ASP A 78 HIS A 84 SITE 2 AC1 5 HOH A 303 SITE 1 AC2 3 ASP A 204 HOH A 408 HOH A 410 CRYST1 88.989 88.989 86.353 90.00 90.00 120.00 P 62 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011237 0.006488 0.000000 0.00000 SCALE2 0.000000 0.012976 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011580 0.00000 MASTER 298 0 2 13 8 0 3 6 0 0 0 20 END